ScinoPharm Taiwan, a leading active pharmaceutical ingredient (API) supplier to the global pharmaceutical and biotechnology industry, announced it has successfully passed a GMP inspection by Japan’s Pharmaceuticals and Medical Devices Agency (PMDA).